Pharmafile Logo

Portcullis Public Affairs

Portcullis Public Affairs is a leading government and communications consultancy, with over 25 years experience offering advice to prominent companies, charities and other organisations in the UK. Health specialisms include public affairs, government relations in the UK and Europe, and crisis management. We help Government reach better decisions. Portcullis is in partnership with MAP BioPharma which helps clients navigate the detailed processes so as to achieve optimal market access in the UK, Ireland and Germany. Together, we provide a unique combination of public affairs capabilities and detailed market analyses.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

11 Haymarket, London, SW1Y 4BP, United Kingdom
+44 (0)20 7368 3100

 Latest Content from PMHub 

MFN Pricing Is Moving Fast – Here’s What Matters

With GENEROUS, GUARD, and GLOBE all released since December, 185 pages of policy will materially impact U.S. drug pricing — and yes, it's a lot to digest. In a new...

ISPOR’s 2026–2027 HEOR Trends report: The Era of Evidence Judgment

In response to ISPOR’s recently published 2026-2027 HEOR Trends, David Miller, CEO, Genesis Research Group, suggests that we’re no longer being evaluated on our ability to produce data, but on...

First impressions matter: Why getting your onboarding right is key for digital engagement

Press Releases | January 20, 2026 | Graphite Digital

As pharma organisations invest extensively in creating engaging content, the onboarding process must not be overlooked. Seamless onboarding is the key to ensuring that HCPs not only meet regulatory standards,...

How can pharma build genuine partnerships with patient communities?

Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates must shape every stage of healthcare and medicines development, driving better outcomes, equity...

How will AI change field training?

Press Releases | January 15, 2026 | Inizio

Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...

The Heart and Mouth Connection Every Woman Needs to Know

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Press Releases | January 7, 2026 | Inizio

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.

MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke

Press Releases | January 7, 2026 | Inizio

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...

Uncovering Inequities in Alzheimer’s Disease Screening and Care

  On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...

Five Predictions That Will Reshape Biopharma Commercialisation in 2026

White Papers and Resources | January 5, 2026 | Nmblr

Every year, we’re met with restructuring, hiring freezes, and portfolio cuts. And every year we tell ourselves the same story. It’s a rough patch. A cycle that will reverse. But...